{
    "other_ids": [
        {
            "name": "Study Protocol Other Identifier",
            "value": "15-003194"
        }
    ],
    "amendment_date": "2021-09-29T00:00:00",
    "keywords": null,
    "dcp_id": null,
    "interventional_model": "Parallel",
    "lead_org": "Mayo Clinic in Rochester",
    "eligibility": {
        "unstructured": [
            {
                "inclusion_indicator": true,
                "display_order": 1,
                "description": "Cohort 1 (dose escalation): histologic or cytologic proof of any solid tumor that is incurable with no standard therapy that is likely to make a major impact on clinical outcomes"
            },
            {
                "inclusion_indicator": true,
                "display_order": 2,
                "description": "Cohort 2 (MTD) only: metastatic adenocarcinoma of the pancreas; prior systemic treatment for metastatic disease is allowed"
            },
            {
                "inclusion_indicator": true,
                "display_order": 3,
                "description": "Cohort 2 (MTD) only: Patient is thought to be a short- or long-term candidate for chemotherapy in the opinion of the treating oncologist"
            },
            {
                "inclusion_indicator": true,
                "display_order": 4,
                "description": "Absolute neutrophil count (ANC) >= 1500/mm^3 (obtained =< 7 days prior to registration)"
            },
            {
                "inclusion_indicator": true,
                "display_order": 5,
                "description": "Platelet >= 100,000/ mm^3 (obtained =< 7 days prior to registration)"
            },
            {
                "inclusion_indicator": true,
                "display_order": 6,
                "description": "Total bilirubin =< 2 x upper limit of normal (ULN) (obtained =< 7 days prior to registration)"
            },
            {
                "inclusion_indicator": true,
                "display_order": 7,
                "description": "Aspartate aminotransferase (AST) (serum glutamic oxaloacetic transaminase [SGOT]) =< 3 x ULN (obtained =< 7 days prior to registration)"
            },
            {
                "inclusion_indicator": true,
                "display_order": 8,
                "description": "Creatinine =< 1.5 x ULN (obtained =< 7 days prior to registration)"
            },
            {
                "inclusion_indicator": true,
                "display_order": 9,
                "description": "Hemoglobin >= 9.0 g/dL (obtained =< 7 days prior to registration)"
            },
            {
                "inclusion_indicator": true,
                "display_order": 10,
                "description": "Cohort 2 (MTD) only: prothrombin time (PT)/international normalized ratio (INR) =< 1.5 x ULN (only if muscle biopsy has not been waived, does not apply to non-Mayo sites that will not be conducting biopsies) (obtained =< 7 days prior to registration)"
            },
            {
                "inclusion_indicator": true,
                "display_order": 11,
                "description": "Ability to provide written informed consent"
            },
            {
                "inclusion_indicator": true,
                "display_order": 12,
                "description": "Life expectancy >= 12 weeks"
            },
            {
                "inclusion_indicator": true,
                "display_order": 13,
                "description": "Cohort 2 (MTD) only: patient willing to undergo muscle biopsies at baseline and after 28 to 35 days of disulfiram/chemotherapy as required by the protocol unless the muscle biopsy has been waived after discussion with the principal investigator (PI); muscle biopsies will not be required at non-Mayo Clinic sites"
            },
            {
                "inclusion_indicator": true,
                "display_order": 14,
                "description": "Cohort 2 (MTD) only: patient willing to have paraffin-embedded slides of the primary pancreas tumor or metastatic site, if available, sent to Mayo investigators for this study"
            },
            {
                "inclusion_indicator": true,
                "display_order": 15,
                "description": "For women of childbearing potential only: negative urine or serum pregnancy test done =< 7 days prior to registration"
            },
            {
                "inclusion_indicator": true,
                "display_order": 16,
                "description": "Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1 or 2"
            },
            {
                "inclusion_indicator": true,
                "display_order": 17,
                "description": "Able to swallow or have medication administered through a gastrostomy tube (G-tube) and absorb the medication"
            },
            {
                "inclusion_indicator": true,
                "display_order": 18,
                "description": "Patient willing to complete a medication diary"
            },
            {
                "inclusion_indicator": true,
                "display_order": 19,
                "description": "Patient agrees to use acceptable form of contraception during the study and for up to 30 days after last study drug dose if female partner is of childbearing potential\r\n* Acceptable forms of contraception:\r\n** Latex condom (always used with spermicide)\r\n** Diaphragm (always used with spermicide)\r\n** Cervical cap (always used with spermicide)\r\n* Acceptable forms of secondary contraception, when used along with a barrier method:\r\n** Hormonal contraception methods, including pills, patches, rings, or injections except progestin-only containing pills (i.e. “Mini-pill”)\r\n** Tubal ligation\r\n** Partner’s vasectomy\r\n** Intrauterine device (non-progesterone T)\r\n** Vaginal sponge (containing spermicide)\r\n* Other acceptable forms:\r\n** 100% commitment to abstinence\r\n* Unacceptable forms of contraception for women of childbearing potential:\r\n** Oral contraception containing progestins only\r\n** Intrauterine device (IUD) progesterone T\r\n** Female condom\r\n** Natural family planning (rhythm method) or breastfeeding\r\n** Fertility awareness\r\n** Withdrawal\r\n** Cervical shield"
            },
            {
                "inclusion_indicator": false,
                "display_order": 20,
                "description": "Known standard therapy for the patient’s disease that is potentially curative"
            },
            {
                "inclusion_indicator": false,
                "display_order": 21,
                "description": "Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, including localized infections, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia or psychiatric illness/social situations that would limit compliance with study requirements"
            },
            {
                "inclusion_indicator": false,
                "display_order": 22,
                "description": "Untreated brain metastases"
            },
            {
                "inclusion_indicator": false,
                "display_order": 23,
                "description": "Any of the following:\r\n* Pregnant women\r\n* Nursing women\r\nThis study involves an investigational agent whose genotoxic, mutagenic and teratogenic effects on the developing fetus and newborn are unknown."
            },
            {
                "inclusion_indicator": false,
                "display_order": 24,
                "description": "Other concurrent chemotherapy, immunotherapy, radiotherapy, any ancillary therapy considered investigational (utilized for a non-Food and Drug Administration [FDA]-approved indication and in the context of a research investigation) or receiving any other investigational agent which would be considered as a treatment for the primary neoplasm"
            },
            {
                "inclusion_indicator": false,
                "display_order": 25,
                "description": "Baseline of grade 2 or worse peripheral sensory neuropathy"
            },
            {
                "inclusion_indicator": false,
                "display_order": 26,
                "description": "Receiving phenytoin"
            },
            {
                "inclusion_indicator": false,
                "display_order": 27,
                "description": "Unable to abstain from alcohol for the duration of the study"
            }
        ],
        "structured": {
            "max_age": "999 Years",
            "max_age_number": 999,
            "min_age_unit": "Years",
            "max_age_unit": "Years",
            "max_age_in_years": 999,
            "gender": "BOTH",
            "min_age": "18 Years",
            "accepts_healthy_volunteers": false,
            "min_age_number": 18,
            "min_age_in_years": 18
        }
    },
    "sites": [
        {
            "org_state_or_province": "MN",
            "contact_name": "Bret E.B. Friday",
            "contact_phone": "612-624-2620",
            "recruitment_status_date": "2021-11-08",
            "org_address_line_2": null,
            "org_va": false,
            "org_address_line_1": "523 Third Street North",
            "org_tty": null,
            "org_family": null,
            "org_postal_code": "56401",
            "contact_email": null,
            "recruitment_status": "TEMPORARILY_CLOSED_TO_ACCRUAL",
            "org_city": "Brainerd",
            "org_email": "CancerTrials@EssentiaHealth.org",
            "org_country": "United States",
            "org_fax": null,
            "org_phone": null,
            "org_name": "Essentia Health Saint Joseph's Medical Center",
            "org_coordinates": {
                "lon": -94.0683,
                "lat": 46.2895
            }
        },
        {
            "org_state_or_province": "MN",
            "contact_name": "Bret E.B. Friday",
            "contact_phone": "218-786-3625",
            "recruitment_status_date": "2021-11-08",
            "org_address_line_2": null,
            "org_va": false,
            "org_address_line_1": "420 East First Street",
            "org_tty": null,
            "org_family": null,
            "org_postal_code": "55805",
            "contact_email": "bret.friday@essentiahealth.org",
            "recruitment_status": "TEMPORARILY_CLOSED_TO_ACCRUAL",
            "org_city": "Duluth",
            "org_email": "CancerTrials@EssentiaHealth.org",
            "org_country": "United States",
            "org_fax": "218-786-3513",
            "org_phone": "218-786-3308",
            "org_name": "Essentia Health Cancer Center",
            "org_coordinates": {
                "lon": -92.0957,
                "lat": 46.8004
            }
        },
        {
            "org_state_or_province": "MN",
            "contact_name": "Bret E.B. Friday",
            "contact_phone": "612-624-2620",
            "recruitment_status_date": "2021-11-08",
            "org_address_line_2": null,
            "org_va": false,
            "org_address_line_1": "730 East 34th Street",
            "org_tty": null,
            "org_family": null,
            "org_postal_code": "55746",
            "contact_email": null,
            "recruitment_status": "TEMPORARILY_CLOSED_TO_ACCRUAL",
            "org_city": "Hibbing",
            "org_email": null,
            "org_country": "United States",
            "org_fax": null,
            "org_phone": null,
            "org_name": "Essentia Health Hibbing Clinic",
            "org_coordinates": {
                "lon": -93.0053,
                "lat": 47.4158
            }
        },
        {
            "org_state_or_province": "MN",
            "contact_name": "Anastas Constantine Provatas",
            "contact_phone": null,
            "recruitment_status_date": "2021-11-08",
            "org_address_line_2": null,
            "org_va": false,
            "org_address_line_1": "750 East 34th Street",
            "org_tty": null,
            "org_family": null,
            "org_postal_code": "55746",
            "contact_email": "ccinfo@umn.edu",
            "recruitment_status": "TEMPORARILY_CLOSED_TO_ACCRUAL",
            "org_city": "Hibbing",
            "org_email": null,
            "org_country": "United States",
            "org_fax": null,
            "org_phone": "218-262-4881",
            "org_name": "Fairview Range Medical Center",
            "org_coordinates": {
                "lon": -93.0053,
                "lat": 47.4158
            }
        },
        {
            "org_state_or_province": "MN",
            "contact_name": "Bret E.B. Friday",
            "contact_phone": "612-624-2620",
            "recruitment_status_date": "2021-11-08",
            "org_address_line_2": null,
            "org_va": false,
            "org_address_line_1": "115 Tenth Avenue Northeast",
            "org_tty": null,
            "org_family": null,
            "org_postal_code": "56636",
            "contact_email": null,
            "recruitment_status": "TEMPORARILY_CLOSED_TO_ACCRUAL",
            "org_city": "Deer River",
            "org_email": "CancerTrials@EssentiaHealth.org",
            "org_country": "United States",
            "org_fax": null,
            "org_phone": null,
            "org_name": "Essentia Health - Deer River Clinic",
            "org_coordinates": {
                "lon": -94.029,
                "lat": 47.4603
            }
        },
        {
            "org_state_or_province": "MN",
            "contact_name": "Bret E.B. Friday",
            "contact_phone": "612-624-2620",
            "recruitment_status_date": "2021-11-08",
            "org_address_line_2": null,
            "org_va": false,
            "org_address_line_1": "1101 Ninth Street North",
            "org_tty": null,
            "org_family": null,
            "org_postal_code": "55792",
            "contact_email": null,
            "recruitment_status": "TEMPORARILY_CLOSED_TO_ACCRUAL",
            "org_city": "Virginia",
            "org_email": "CancerTrials@EssentiaHealth.org",
            "org_country": "United States",
            "org_fax": null,
            "org_phone": "844-681-7944",
            "org_name": "Essentia Health Virginia Clinic",
            "org_coordinates": {
                "lon": -92.4535,
                "lat": 47.6048
            }
        },
        {
            "org_state_or_province": "MN",
            "contact_name": "Bret E.B. Friday",
            "contact_phone": "612-624-2620",
            "recruitment_status_date": "2021-11-08",
            "org_address_line_2": null,
            "org_va": false,
            "org_address_line_1": "900 Hilligoss Boulevard Southeast",
            "org_tty": null,
            "org_family": null,
            "org_postal_code": "56542",
            "contact_email": null,
            "recruitment_status": "TEMPORARILY_CLOSED_TO_ACCRUAL",
            "org_city": "Fosston",
            "org_email": "CancerTrials@EssentiaHealth.org",
            "org_country": "United States",
            "org_fax": null,
            "org_phone": "(701)-364-6272",
            "org_name": "Essentia Health - Fosston",
            "org_coordinates": {
                "lon": -95.7461,
                "lat": 47.587
            }
        },
        {
            "org_state_or_province": "MN",
            "contact_name": "Bret E.B. Friday",
            "contact_phone": "612-624-2620",
            "recruitment_status_date": "2021-11-08",
            "org_address_line_2": null,
            "org_va": false,
            "org_address_line_1": "1027 Washington Avenue",
            "org_tty": null,
            "org_family": null,
            "org_postal_code": "56501",
            "contact_email": null,
            "recruitment_status": "TEMPORARILY_CLOSED_TO_ACCRUAL",
            "org_city": "Detroit Lakes",
            "org_email": "CancerTrials@EssentiaHealth.org",
            "org_country": "United States",
            "org_fax": null,
            "org_phone": "(701)-364-6272",
            "org_name": "Essentia Health Saint Mary's - Detroit Lakes Clinic",
            "org_coordinates": {
                "lon": -95.6596,
                "lat": 46.9503
            }
        },
        {
            "org_state_or_province": "MN",
            "contact_name": "Bret E.B. Friday",
            "contact_phone": "612-624-2620",
            "recruitment_status_date": "2021-11-08",
            "org_address_line_2": null,
            "org_va": false,
            "org_address_line_1": "705 Pleasant Avenue",
            "org_tty": null,
            "org_family": null,
            "org_postal_code": "56470",
            "contact_email": null,
            "recruitment_status": "TEMPORARILY_CLOSED_TO_ACCRUAL",
            "org_city": "Park Rapids",
            "org_email": "CancerTrials@EssentiaHealth.org",
            "org_country": "United States",
            "org_fax": null,
            "org_phone": "(701)-364-6272",
            "org_name": "Essentia Health - Park Rapids",
            "org_coordinates": {
                "lon": -95.0029,
                "lat": 46.9966
            }
        },
        {
            "org_state_or_province": "MN",
            "contact_name": "Jonathan Bleeker",
            "contact_phone": null,
            "recruitment_status_date": "2021-11-08",
            "org_address_line_2": null,
            "org_va": false,
            "org_address_line_1": "1018 Sixth Avenue",
            "org_tty": null,
            "org_family": null,
            "org_postal_code": "56187",
            "contact_email": "jonathan.bleeker@sanfordhealth.org",
            "recruitment_status": "TEMPORARILY_CLOSED_TO_ACCRUAL",
            "org_city": "Worthington",
            "org_email": null,
            "org_country": "United States",
            "org_fax": null,
            "org_phone": "(605)-312-3320",
            "org_name": "Sanford Cancer Center Worthington",
            "org_coordinates": {
                "lon": -95.6043,
                "lat": 43.698
            }
        },
        {
            "org_state_or_province": "MN",
            "contact_name": "Amit Waman Panwalkar",
            "contact_phone": "612-624-2620",
            "recruitment_status_date": "2021-11-08",
            "org_address_line_2": null,
            "org_va": false,
            "org_address_line_1": "3001 Sanford Parkway",
            "org_tty": null,
            "org_family": null,
            "org_postal_code": "56701",
            "contact_email": null,
            "recruitment_status": "TEMPORARILY_CLOSED_TO_ACCRUAL",
            "org_city": "Thief River Falls",
            "org_email": null,
            "org_country": "United States",
            "org_fax": null,
            "org_phone": "(605)-312-3320",
            "org_name": "Sanford Thief River Falls Medical Center",
            "org_coordinates": {
                "lon": -96.1186,
                "lat": 48.0818
            }
        },
        {
            "org_state_or_province": "MN",
            "contact_name": "Daniel M. Anderson",
            "contact_phone": null,
            "recruitment_status_date": "2021-11-08",
            "org_address_line_2": "Suite 50",
            "org_va": false,
            "org_address_line_1": "1001 Hart Boulevard",
            "org_tty": null,
            "org_family": null,
            "org_postal_code": "55362",
            "contact_email": "ccinfo@umn.edu",
            "recruitment_status": "TEMPORARILY_CLOSED_TO_ACCRUAL",
            "org_city": "Monticello",
            "org_email": "mmcorc@healthpartners.com",
            "org_country": "United States",
            "org_fax": null,
            "org_phone": "(952)-993-1517",
            "org_name": "Monticello Cancer Center",
            "org_coordinates": {
                "lon": -93.7941,
                "lat": 45.2795
            }
        },
        {
            "org_state_or_province": "MN",
            "contact_name": "Bret E.B. Friday",
            "contact_phone": "612-624-2620",
            "recruitment_status_date": "2021-11-08",
            "org_address_line_2": null,
            "org_va": false,
            "org_address_line_1": "705 Lundorff Drive",
            "org_tty": null,
            "org_family": null,
            "org_postal_code": "55072",
            "contact_email": null,
            "recruitment_status": "TEMPORARILY_CLOSED_TO_ACCRUAL",
            "org_city": "Sandstone",
            "org_email": "CancerTrials@EssentiaHealth.org",
            "org_country": "United States",
            "org_fax": null,
            "org_phone": "(701)-364-6272",
            "org_name": "Essentia Health Sandstone",
            "org_coordinates": {
                "lon": -92.5611,
                "lat": 46.138
            }
        },
        {
            "org_state_or_province": "MN",
            "contact_name": "Anastas Constantine Provatas",
            "contact_phone": null,
            "recruitment_status_date": "2021-11-08",
            "org_address_line_2": null,
            "org_va": false,
            "org_address_line_1": "911 Northland Drive",
            "org_tty": null,
            "org_family": null,
            "org_postal_code": "55371",
            "contact_email": "ccinfo@umn.edu",
            "recruitment_status": "TEMPORARILY_CLOSED_TO_ACCRUAL",
            "org_city": "Princeton",
            "org_email": "mmcorc@healthpartners.com",
            "org_country": "United States",
            "org_fax": null,
            "org_phone": "(952)-993-1517",
            "org_name": "Fairview Northland Medical Center",
            "org_coordinates": {
                "lon": -93.6306,
                "lat": 45.6019
            }
        },
        {
            "org_state_or_province": "MN",
            "contact_name": "Anastas Constantine Provatas",
            "contact_phone": "612-624-2620",
            "recruitment_status_date": "2021-11-08",
            "org_address_line_2": null,
            "org_va": false,
            "org_address_line_1": "1601 Golf Course Road",
            "org_tty": null,
            "org_family": null,
            "org_postal_code": "Grand Rapids",
            "contact_email": "ccinfo@umn.edu",
            "recruitment_status": "TEMPORARILY_CLOSED_TO_ACCRUAL",
            "org_city": "Grand Rapids",
            "org_email": null,
            "org_country": "United States",
            "org_fax": null,
            "org_phone": "218-326-3401",
            "org_name": "Fairview Grand Itasca Clinic & Hospital"
        },
        {
            "org_state_or_province": "MN",
            "contact_name": "Aminah Jatoi",
            "contact_phone": "507-284-2511",
            "recruitment_status_date": "2022-01-07",
            "org_address_line_2": null,
            "org_va": false,
            "org_address_line_1": "200 First Street Southwest",
            "org_tty": null,
            "org_family": "Mayo Clinic Cancer Center",
            "org_postal_code": "55905",
            "contact_email": null,
            "recruitment_status": "ACTIVE",
            "org_city": "Rochester",
            "org_email": null,
            "org_country": "United States",
            "org_fax": "507-284-0161",
            "org_phone": "507-538-7623",
            "org_name": "Mayo Clinic in Rochester",
            "org_coordinates": {
                "lon": -92.4912,
                "lat": 44.0368
            }
        }
    ],
    "completion_date_type_code": "ANTICIPATED",
    "detail_description": "PRIMARY OBJECTIVE:\r\nI. To determine the maximally tolerated dose (MTD) of the combination of disulfiram and gemcitabine (gemcitabine hydrochloride) in unresectable solid tumor cancer patients (Cohort 1).\r\n\r\nSECONDARY OBJECTIVES:\r\nI. To describe the adverse event profile associated with this combination of disulfiram and chemotherapy (Cohort 2).\r\nII. To describe changes in muscle area at the L3 level from baseline to 28 to 60 days from the baseline computed tomography (CT) scan in patients treated with disulfiram/chemotherapy and with placebo/chemotherapy (Cohort 2).\r\nIII. To describe changes in fist-grip strength from baseline to 28 to 35 days of treatment with disulfiram/gemcitabine and with placebo/chemotherapy (Cohort 2).\r\nIV. To describe overall survival of pancreas cancer patients who disulfiram/chemotherapy or placebo/chemotherapy (Cohort 2).\r\nV. To estimate the response rate per Response Evaluation Criteria in Solid Tumors (RECIST) criteria around 1 month post-treatment in patients who receive disulfiram/chemotherapy and placebo/chemotherapy (Cohort 2).\r\n\r\nCORRELATIVE OBJECTIVE:\r\nI. To assess the effect of disulfiram and chemotherapy on the ubiquitin proteasome and autophagy pathways within muscle, as assessed by means of muscle biopsies performed at baseline and after 28 to 35 days of treatment (Cohort 2) (this is for Mayo only patients and can be waived upon permission from the principal investigator [PI]).\r\n\r\nOUTLINE: This is a phase I, dose-escalation study of disulfiram. \r\n\r\nCOHORT I: Patients receive gemcitabine hydrochloride intravenously (IV) over 30 minutes on days 1, 8, and 15 and disulfiram orally (PO) on days 1-28 or days 1-35.\r\n\r\nCOHORT II: Patients receive chemotherapy at the discretion of the treating oncologist and disulfiram PO on days 1-28 or days 1-35.\r\n\r\nAfter completion of study treatment, patients are followed up at 30 days, and then every 6 months for 3 years.",
    "official_title": "Expansion Cohort Study of Disulfiram and Chemotherapy in Pancreas Cancer Patients",
    "_phase_sort_order": 4,
    "collaborators": [
        {
            "name": "National Cancer Institute",
            "functional_role": "FUNDING_SOURCE"
        }
    ],
    "associated_studies": null,
    "outcome_measures": [
        {
            "time_frame": "Up to 30 days post-treatment",
            "name": "Adverse events profile (Cohort I and II)",
            "description": "The number and severity of all adverse events (overall, by dose-level, and by tumor group) will be tabulated and summarized in this patient population. The grade 3+ adverse events will also be described and summarized in a similar fashion. This will provide an indication of the level of tolerance for this treatment combination in this patient group.",
            "type_code": "SECONDARY"
        },
        {
            "time_frame": "Baseline to day 28",
            "name": "Change in muscle area at the L3 level using a computed tomography (CT) scan (Cohort II)",
            "description": "Changes will be described using summary statistics and graphical techniques. A grayscale pixel histogram of the remaining muscle in the image will be constructed and summed. The number of pixels will then be converted to an area measurement in squared centimeters. All measurements and calculations for each image will be undertaken by two independent study personnel, and the average will be used in the analyses. A Wilcoxon rank sum test may be used as appropriate to compare percent changes of biomarkers between the muscle clinical responders and the non-responders based on CT scan measurements of muscle.",
            "type_code": "SECONDARY"
        },
        {
            "time_frame": "Baseline to day 35",
            "name": "Change in muscle area at the L3 level using a computed tomography scan (Cohort II)",
            "description": "Changes will be described using summary statistics and graphical techniques. A grayscale pixel histogram of the remaining muscle in the image will be constructed and summed. The number of pixels will then be converted to an area measurement in squared centimeters. All measurements and calculations for each image will be undertaken by two independent study personnel, and the average will be used in the analyses. A Wilcoxon rank sum test may be used as appropriate to compare percent changes of biomarkers between the muscle clinical responders and the non-responders based on CT scan measurements of muscle.",
            "type_code": "SECONDARY"
        },
        {
            "time_frame": "Baseline to up to 35 days",
            "name": "Change in muscle protein expression level of total and phosphorylated (phosph)-signal transducer and activator of transcription 3 (STAT3) via immunohistochemistry",
            "description": "Changes will be made at baseline and 28 to 35 days.",
            "type_code": "OTHER_PRE_SPECIFIED"
        },
        {
            "time_frame": "Baseline to day 28",
            "name": "Changes in fist-grip strength as measured by hand dynamometer (Cohort II)",
            "description": "Changes will be described using summary statistics and graphical techniques. Patients will use 3 successive tries, and the average value will be used.",
            "type_code": "SECONDARY"
        },
        {
            "time_frame": "Baseline to day 35",
            "name": "Changes in fist-grip strength as measured by hand dynamometer (Cohort II)",
            "description": "Changes will be described using summary statistics and graphical techniques. Patients will use 3 successive tries, and the average value will be used.",
            "type_code": "SECONDARY"
        },
        {
            "time_frame": "Baseline to up to 35 days",
            "name": "Changes in muscle messenger ribonucleic acid (mRNA) levels via real-time polymerase chain reaction",
            "description": "Changes in mRNA transcripts of the muscle ubiquitin proteasome system (atrogin and muscle-specific RING finger protein 1) and STAT3 target genes (suppressor of cytokine signaling 3 and early growth response 1) will be made at baseline and 28 to 35 days.",
            "type_code": "OTHER_PRE_SPECIFIED"
        },
        {
            "time_frame": "28 days",
            "name": "Maximum tolerated dose (MTD) (Cohort I)",
            "description": "MTD is defined as the dose level below the lowest dose that induces dose limiting toxicity (DLT) in at least one-third of patients (at least 2 of a maximum of 6 new patients).",
            "type_code": "PRIMARY"
        },
        {
            "time_frame": "From registration until death due to any cause, assessed up to 3 years",
            "name": "Overall survival (OS) (Cohort I and II)",
            "description": "OS will be summarized descriptively using the Kaplan-Meier estimate up to 3 years of follow-up in all alive patients.",
            "type_code": "SECONDARY"
        },
        {
            "time_frame": "At 1 month post-treatment",
            "name": "Response rate (Cohort II)",
            "description": "Response rate will be assessed using standard Response Evaluation Criteria In Solid Tumors (RECIST) 1.1 criteria.",
            "type_code": "SECONDARY"
        },
        {
            "time_frame": "Up to 30 days post-treatment",
            "name": "Toxicity profile defined as adverse events that are classified as either possibly, probably, or definitely related to study treatment (Cohorts I and II)",
            "description": "Non-hematologic toxicities will be evaluated via the ordinal Common Terminology Criteria (CTC) standard toxicity grading. Hematologic toxicity measures of thrombocytopenia, neutropenia, and leukopenia will be assessed using continuous variables as the outcome measures (primarily nadir) as well as categorization via CTC standard toxicity grading. Overall toxicity incidence as well as toxicity profiles by dose level, patient and tumor site will be explored and summarized. Frequency distributions, graphical techniques and other descriptive measures will form the basis of these analyses.",
            "type_code": "SECONDARY"
        }
    ],
    "phase": "I",
    "central_contact": {
        "phone": null,
        "name": null,
        "type": null,
        "email": null
    },
    "primary_purpose": "TREATMENT",
    "number_of_arms": 2,
    "_study_protocol_type_sort_order": 0,
    "nct_id": "NCT02671890",
    "biomarkers": null,
    "classification_code": "SAFETY",
    "current_trial_status_date": "2021-11-08",
    "diseases": [
        {
            "inclusion_indicator": "TRIAL",
            "is_lead_disease": true,
            "synonyms": [
                "Refractory Malignant Solid Neoplasm"
            ],
            "nci_thesaurus_concept_id": "C133737",
            "name": "Refractory Malignant Solid Tumor",
            "type": [
                "subtype"
            ],
            "parents": [
                "C132146",
                "C120186"
            ]
        },
        {
            "inclusion_indicator": "TRIAL",
            "is_lead_disease": false,
            "synonyms": [
                "Stage IV",
                "Stage IV Exocrine Pancreatic Cancer AJCC v8",
                "Stage IV Exocrine Pancreatic Carcinoma AJCC v8",
                "Stage IV Pancreatic Cancer AJCC v8"
            ],
            "nci_thesaurus_concept_id": "C134930",
            "name": "Stage IV Pancreatic Cancer",
            "type": [
                "stage"
            ],
            "parents": [
                "C134909"
            ]
        },
        {
            "inclusion_indicator": "TRIAL",
            "is_lead_disease": false,
            "synonyms": [],
            "nci_thesaurus_concept_id": "C8933",
            "name": "Metastatic Pancreatic Adenocarcinoma",
            "type": [
                "subtype"
            ],
            "parents": [
                "C4124",
                "C156069",
                "C8294"
            ]
        },
        {
            "inclusion_indicator": "TREE",
            "is_lead_disease": false,
            "synonyms": [],
            "nci_thesaurus_concept_id": "C162255",
            "name": "Metastatic Malignant Digestive System Neoplasm",
            "type": [
                "subtype"
            ],
            "parents": [
                "C4890",
                "C36263"
            ]
        },
        {
            "inclusion_indicator": "TREE",
            "is_lead_disease": true,
            "synonyms": [
                "Solid Neoplasm",
                "Solid Tumour",
                "Solid tumor, NOS",
                "solid tumor"
            ],
            "nci_thesaurus_concept_id": "C9292",
            "name": "Solid Tumor",
            "type": [
                "maintype"
            ],
            "parents": [
                "C7062"
            ]
        },
        {
            "inclusion_indicator": "TREE",
            "is_lead_disease": true,
            "synonyms": [
                "Refractory Tumor",
                "Refractory tumor"
            ],
            "nci_thesaurus_concept_id": "C7628",
            "name": "Refractory Neoplasm",
            "type": [
                "subtype"
            ],
            "parents": [
                "C7062"
            ]
        },
        {
            "inclusion_indicator": "TREE",
            "is_lead_disease": false,
            "synonyms": [
                "Neoplasm of Pancreas",
                "Neoplasm of the Pancreas",
                "Pancreas Neoplasm",
                "Pancreas Tumor",
                "Pancreatic Tumor",
                "Tumor of Pancreas",
                "Tumor of the Pancreas"
            ],
            "nci_thesaurus_concept_id": "C3305",
            "name": "Pancreatic Neoplasm",
            "type": [
                "subtype"
            ],
            "parents": [
                "C3052",
                "C26842"
            ]
        },
        {
            "inclusion_indicator": "TREE",
            "is_lead_disease": false,
            "synonyms": [
                "Carcinoma, metastatic, NOS"
            ],
            "nci_thesaurus_concept_id": "C3482",
            "name": "Metastatic Carcinoma",
            "type": [
                "subtype"
            ],
            "parents": [
                "C36263",
                "C36310"
            ]
        },
        {
            "inclusion_indicator": "TREE",
            "is_lead_disease": false,
            "synonyms": [
                "Tumor Morphology",
                "Tumor_Morphology"
            ],
            "nci_thesaurus_concept_id": "C4741",
            "name": "Neoplasm by Morphology",
            "type": [
                "subtype"
            ],
            "parents": [
                "C3262"
            ]
        },
        {
            "inclusion_indicator": "TREE",
            "is_lead_disease": false,
            "synonyms": [
                "Epithelial Neoplasms, NOS",
                "Epithelioma",
                "Epithelioma, malignant"
            ],
            "nci_thesaurus_concept_id": "C3709",
            "name": "Epithelial Neoplasm",
            "type": [
                "subtype"
            ],
            "parents": [
                "C4741"
            ]
        },
        {
            "inclusion_indicator": "TREE",
            "is_lead_disease": true,
            "synonyms": [
                "Malignant Solid Neoplasm"
            ],
            "nci_thesaurus_concept_id": "C132146",
            "name": "Malignant Solid Tumor",
            "type": [
                "subtype"
            ],
            "parents": [
                "C9305",
                "C9292"
            ]
        },
        {
            "inclusion_indicator": "TREE",
            "is_lead_disease": false,
            "synonyms": [],
            "nci_thesaurus_concept_id": "C7057",
            "name": "Disease, Disorder or Finding",
            "type": [],
            "parents": []
        },
        {
            "inclusion_indicator": "TREE",
            "is_lead_disease": false,
            "synonyms": [
                "Cancer of Pancreas",
                "Cancer of the Pancreas",
                "Carcinoma of Pancreas",
                "Carcinoma of the Pancreas",
                "Exocrine Pancreas Carcinoma",
                "Pancreas Cancer",
                "Pancreas Carcinoma",
                "Pancreatic Carcinoma",
                "Pancreatic cancer (excluding Islets), NOS",
                "Pancreatic cancer (not Islets)",
                "exocrine cancer",
                "pancreatic cancer"
            ],
            "nci_thesaurus_concept_id": "C3850",
            "name": "Pancreatic Cancer",
            "type": [
                "maintype"
            ],
            "parents": [
                "C7430",
                "C166418"
            ]
        },
        {
            "inclusion_indicator": "TREE",
            "is_lead_disease": false,
            "synonyms": [
                "Secondary carcinoma"
            ],
            "nci_thesaurus_concept_id": "C36310",
            "name": "Secondary Carcinoma",
            "type": [
                "subtype"
            ],
            "parents": [
                "C2916",
                "C4968"
            ]
        },
        {
            "inclusion_indicator": "TREE",
            "is_lead_disease": true,
            "synonyms": [],
            "nci_thesaurus_concept_id": "C7057",
            "name": "Disease, Disorder or Finding",
            "type": [],
            "parents": []
        },
        {
            "inclusion_indicator": "TREE",
            "is_lead_disease": false,
            "synonyms": [],
            "nci_thesaurus_concept_id": "C3263",
            "name": "Neoplasm by Site",
            "type": [
                "subtype"
            ],
            "parents": [
                "C3262"
            ]
        },
        {
            "inclusion_indicator": "TREE",
            "is_lead_disease": true,
            "synonyms": [
                "Neoplasia",
                "Neoplasm",
                "Neoplasm, NOS",
                "Neoplasms, NOS",
                "Neoplastic Disease",
                "Neoplastic Growth",
                "Tumor, NOS",
                "neoplasia",
                "neoplasm",
                "tumor"
            ],
            "nci_thesaurus_concept_id": "C3262",
            "name": "Other Neoplasm",
            "type": [
                "maintype"
            ],
            "parents": [
                "C2991"
            ]
        },
        {
            "inclusion_indicator": "TREE",
            "is_lead_disease": false,
            "synonyms": [
                "Malignant Exocrine Pancreas Tumor",
                "Malignant Neoplasm of Exocrine Pancreas",
                "Malignant Neoplasm of the Exocrine Pancreas",
                "Malignant Tumor of Exocrine Pancreas",
                "Malignant Tumor of the Exocrine Pancreas"
            ],
            "nci_thesaurus_concept_id": "C7430",
            "name": "Malignant Exocrine Pancreas Neoplasm",
            "type": [
                "subtype"
            ],
            "parents": [
                "C9005",
                "C4445"
            ]
        },
        {
            "inclusion_indicator": "TREE",
            "is_lead_disease": false,
            "synonyms": [
                "Neoplasia",
                "Neoplasm",
                "Neoplasm, NOS",
                "Neoplasms, NOS",
                "Neoplastic Disease",
                "Neoplastic Growth",
                "Tumor, NOS",
                "neoplasia",
                "neoplasm",
                "tumor"
            ],
            "nci_thesaurus_concept_id": "C3262",
            "name": "Other Neoplasm",
            "type": [
                "maintype"
            ],
            "parents": [
                "C2991"
            ]
        },
        {
            "inclusion_indicator": "TREE",
            "is_lead_disease": false,
            "synonyms": [
                "ADENOCARCINOMA, MALIGNANT",
                "Adenocarcinoma, NOS",
                "adenocarcinoma"
            ],
            "nci_thesaurus_concept_id": "C2852",
            "name": "Adenocarcinoma",
            "type": [
                "subtype"
            ],
            "parents": [
                "C2916",
                "C7132"
            ]
        },
        {
            "inclusion_indicator": "TREE",
            "is_lead_disease": false,
            "synonyms": [
                "Carcinoma of the Gastrointestinal System",
                "Gastrointestinal System Carcinoma"
            ],
            "nci_thesaurus_concept_id": "C96963",
            "name": "Digestive System Carcinoma",
            "type": [
                "subtype"
            ],
            "parents": [
                "C2916",
                "C4890"
            ]
        },
        {
            "inclusion_indicator": "TREE",
            "is_lead_disease": false,
            "synonyms": [
                "Metastatic Cancer"
            ],
            "nci_thesaurus_concept_id": "C36263",
            "name": "Metastatic Malignant Neoplasm",
            "type": [
                "subtype"
            ],
            "parents": [
                "C3261",
                "C4968"
            ]
        },
        {
            "inclusion_indicator": "TREE",
            "is_lead_disease": false,
            "synonyms": [
                "Digestive Neoplasm",
                "Digestive System Tumor",
                "Digestive Tumor",
                "GI Neoplasm",
                "GI System Neoplasm",
                "GI System Tumor",
                "GI Tumor",
                "Gastrointestinal Neoplasm",
                "Gastrointestinal System Neoplasm",
                "Gastrointestinal System Tumor",
                "Gastrointestinal Tumor",
                "Neoplasm of Digestive System",
                "Neoplasm of GI System",
                "Neoplasm of Gastrointestinal System",
                "Neoplasm of the Digestive System",
                "Neoplasm of the GI System",
                "Neoplasm of the Gastrointestinal System",
                "Tumor of Digestive System",
                "Tumor of GI System",
                "Tumor of Gastrointestinal System",
                "Tumor of the Digestive System",
                "Tumor of the GI System",
                "Tumor of the Gastrointestinal System"
            ],
            "nci_thesaurus_concept_id": "C3052",
            "name": "Digestive System Neoplasm",
            "type": [
                "subtype"
            ],
            "parents": [
                "C2990",
                "C3263"
            ]
        },
        {
            "inclusion_indicator": "TREE",
            "is_lead_disease": false,
            "synonyms": [
                "Adenocarcinoma - pancreas",
                "Adenocarcinoma of Pancreas",
                "Adenocarcinoma of the Pancreas",
                "Adenocarcinoma of the pancreas",
                "Pancreas Adenocarcinoma"
            ],
            "nci_thesaurus_concept_id": "C8294",
            "name": "Pancreatic Adenocarcinoma",
            "type": [
                "subtype"
            ],
            "parents": [
                "C2852",
                "C3850"
            ]
        },
        {
            "inclusion_indicator": "TREE",
            "is_lead_disease": true,
            "synonyms": [],
            "nci_thesaurus_concept_id": "C7062",
            "name": "Neoplasm by Special Category",
            "type": [
                "subtype"
            ],
            "parents": [
                "C3262"
            ]
        },
        {
            "inclusion_indicator": "TREE",
            "is_lead_disease": false,
            "synonyms": [],
            "nci_thesaurus_concept_id": "C7062",
            "name": "Neoplasm by Special Category",
            "type": [
                "subtype"
            ],
            "parents": [
                "C3262"
            ]
        },
        {
            "inclusion_indicator": "TREE",
            "is_lead_disease": false,
            "synonyms": [
                "Secondary Cancer",
                "Secondary Malignancy",
                "secondary cancer"
            ],
            "nci_thesaurus_concept_id": "C4968",
            "name": "Secondary Malignant Neoplasm",
            "type": [
                "subtype"
            ],
            "parents": [
                "C9305",
                "C36255"
            ]
        },
        {
            "inclusion_indicator": "TREE",
            "is_lead_disease": false,
            "synonyms": [
                "Pancreaticobiliary Cancer",
                "Pancreaticobiliary Carcinoma",
                "Pancreatobiliary Cancer"
            ],
            "nci_thesaurus_concept_id": "C166418",
            "name": "Pancreatobiliary Carcinoma",
            "type": [
                "subtype"
            ],
            "parents": [
                "C96963"
            ]
        },
        {
            "inclusion_indicator": "TREE",
            "is_lead_disease": false,
            "synonyms": [
                "Metastatic Digestive System Carcinoma",
                "Metastatic Gastrointestinal Carcinoma",
                "Metastatic Gastrointestinal System Cancer",
                "Metastatic Gastrointestinal System Carcinoma"
            ],
            "nci_thesaurus_concept_id": "C133839",
            "name": "Metastatic Digestive System Cancer",
            "type": [
                "subtype"
            ],
            "parents": [
                "C96963",
                "C3482",
                "C162255"
            ]
        },
        {
            "inclusion_indicator": "TREE",
            "is_lead_disease": true,
            "synonyms": [
                "Refractory Cancer",
                "clinical resistance",
                "refractory cancer",
                "resistant cancer"
            ],
            "nci_thesaurus_concept_id": "C120186",
            "name": "Refractory Malignant Neoplasm",
            "type": [
                "subtype"
            ],
            "parents": [
                "C9305",
                "C7628"
            ]
        },
        {
            "inclusion_indicator": "TREE",
            "is_lead_disease": false,
            "synonyms": [
                "Metastatic Tumor",
                "Neoplasm, metastatic",
                "Tumor, metastatic"
            ],
            "nci_thesaurus_concept_id": "C3261",
            "name": "Metastatic Neoplasm",
            "type": [
                "subtype"
            ],
            "parents": [
                "C7062"
            ]
        },
        {
            "inclusion_indicator": "TREE",
            "is_lead_disease": false,
            "synonyms": [
                "CARCINOMA, MALIGNANT",
                "Carcinoma",
                "Carcinoma, NOS",
                "Epithelial Carcinoma",
                "Epithelial tumor, malignant",
                "Epithelioma Malignant",
                "Malignant Epithelial Neoplasm",
                "Malignant Epithelial Tumor",
                "Malignant Epithelioma",
                "carcinoma",
                "epithelial carcinoma"
            ],
            "nci_thesaurus_concept_id": "C2916",
            "name": "Other Carcinoma",
            "type": [
                "maintype"
            ],
            "parents": [
                "C3709",
                "C9305"
            ]
        },
        {
            "inclusion_indicator": "TREE",
            "is_lead_disease": false,
            "synonyms": [
                "Diagnosis",
                "Disease",
                "Disease or Disorder",
                "Disease or Disorder, Non-Neoplastic",
                "Diseases",
                "Diseases and Disorders",
                "Disorder",
                "Disorders",
                "condition",
                "disease",
                "disease term",
                "disease type",
                "disease_term",
                "disease_type",
                "disorder"
            ],
            "nci_thesaurus_concept_id": "C2991",
            "name": "Other Disease",
            "type": [
                "maintype"
            ],
            "parents": [
                "C7057"
            ]
        },
        {
            "inclusion_indicator": "TREE",
            "is_lead_disease": true,
            "synonyms": [
                "Diagnosis",
                "Disease",
                "Disease or Disorder",
                "Disease or Disorder, Non-Neoplastic",
                "Diseases",
                "Diseases and Disorders",
                "Disorder",
                "Disorders",
                "condition",
                "disease",
                "disease term",
                "disease type",
                "disease_term",
                "disease_type",
                "disorder"
            ],
            "nci_thesaurus_concept_id": "C2991",
            "name": "Other Disease",
            "type": [
                "maintype"
            ],
            "parents": [
                "C7057"
            ]
        },
        {
            "inclusion_indicator": "TREE",
            "is_lead_disease": false,
            "synonyms": [],
            "nci_thesaurus_concept_id": "C26842",
            "name": "Pancreatic Disorder",
            "type": [
                "subtype"
            ],
            "parents": [
                "C2990"
            ]
        },
        {
            "inclusion_indicator": "TREE",
            "is_lead_disease": false,
            "synonyms": [
                "Exocrine Pancreatic Cancer by AJCC v8 Stage",
                "Exocrine Pancreatic Carcinoma by AJCC v8 Stage",
                "Tumor Stage (Pathological)"
            ],
            "nci_thesaurus_concept_id": "C134909",
            "name": "Pancreatic Cancer by AJCC v8 Stage",
            "type": [
                "stage"
            ],
            "parents": [
                "C3850"
            ]
        },
        {
            "inclusion_indicator": "TREE",
            "is_lead_disease": false,
            "synonyms": [
                "Adenocarcinoma, metastatic, NOS"
            ],
            "nci_thesaurus_concept_id": "C4124",
            "name": "Metastatic Adenocarcinoma",
            "type": [
                "subtype"
            ],
            "parents": [
                "C2852",
                "C3482"
            ]
        },
        {
            "inclusion_indicator": "TREE",
            "is_lead_disease": false,
            "synonyms": [
                "Gastrointestinal System Cancer",
                "Gastrointestinal cancer, NOS",
                "Malignant Digestive System Neoplasm",
                "Malignant Gastrointestinal System Neoplasm"
            ],
            "nci_thesaurus_concept_id": "C4890",
            "name": "Malignant Gastrointestinal Neoplasm",
            "type": [
                "subtype"
            ],
            "parents": [
                "C3052",
                "C9305"
            ]
        },
        {
            "inclusion_indicator": "TREE",
            "is_lead_disease": false,
            "synonyms": [
                "Disease by Site"
            ],
            "nci_thesaurus_concept_id": "C27551",
            "name": "Disorder by Site",
            "type": [
                "subtype"
            ],
            "parents": [
                "C2991"
            ]
        },
        {
            "inclusion_indicator": "TREE",
            "is_lead_disease": false,
            "synonyms": [],
            "nci_thesaurus_concept_id": "C156069",
            "name": "Metastatic Pancreatic Carcinoma",
            "type": [
                "subtype"
            ],
            "parents": [
                "C155852",
                "C170458",
                "C3850"
            ]
        },
        {
            "inclusion_indicator": "TREE",
            "is_lead_disease": false,
            "synonyms": [
                "Neoplasm, secondary",
                "Secondary Tumor",
                "Tumor, secondary",
                "secondary tumor"
            ],
            "nci_thesaurus_concept_id": "C36255",
            "name": "Secondary Neoplasm",
            "type": [
                "subtype"
            ],
            "parents": [
                "C7062"
            ]
        },
        {
            "inclusion_indicator": "TREE",
            "is_lead_disease": false,
            "synonyms": [
                "Glandular Cell Epithelial Neoplasm",
                "Glandular Cell Epithelium Neoplasm"
            ],
            "nci_thesaurus_concept_id": "C7132",
            "name": "Glandular Cell Neoplasm",
            "type": [
                "subtype"
            ],
            "parents": [
                "C3709"
            ]
        },
        {
            "inclusion_indicator": "TREE",
            "is_lead_disease": false,
            "synonyms": [
                "Digestive Disease",
                "Digestive System Disease",
                "Disorder of Digestive System",
                "Gastrointestinal Disorder",
                "Gastrointestinal System Disease",
                "Gastrointestinal System Disorder",
                "Unspecified Gastrointestinal Problem",
                "stomach or intestinal disorder"
            ],
            "nci_thesaurus_concept_id": "C2990",
            "name": "Digestive System Disorder",
            "type": [
                "subtype"
            ],
            "parents": [
                "C27551"
            ]
        },
        {
            "inclusion_indicator": "TREE",
            "is_lead_disease": false,
            "synonyms": [
                "Malignant Neoplasm of Pancreas",
                "Malignant Neoplasm of the Pancreas"
            ],
            "nci_thesaurus_concept_id": "C9005",
            "name": "Malignant Pancreatic Neoplasm",
            "type": [
                "subtype"
            ],
            "parents": [
                "C4890",
                "C3305"
            ]
        },
        {
            "inclusion_indicator": "TREE",
            "is_lead_disease": false,
            "synonyms": [],
            "nci_thesaurus_concept_id": "C170458",
            "name": "Metastatic Pancreatobiliary Carcinoma",
            "type": [
                "subtype"
            ],
            "parents": [
                "C133839",
                "C166418"
            ]
        },
        {
            "inclusion_indicator": "TREE",
            "is_lead_disease": false,
            "synonyms": [],
            "nci_thesaurus_concept_id": "C155852",
            "name": "Metastatic Malignant Pancreatic Neoplasm",
            "type": [
                "subtype"
            ],
            "parents": [
                "C9005",
                "C36263"
            ]
        },
        {
            "inclusion_indicator": "TREE",
            "is_lead_disease": false,
            "synonyms": [
                "Exocrine Pancreas Neoplasm",
                "Exocrine Pancreas Tumor",
                "Neoplasm of Exocrine Pancreas",
                "Neoplasm of the Exocrine Pancreas",
                "Pancreatic Exocrine Tumor",
                "Tumor of Exocrine Pancreas",
                "Tumor of the Exocrine Pancreas"
            ],
            "nci_thesaurus_concept_id": "C4445",
            "name": "Pancreatic Exocrine Neoplasm",
            "type": [
                "subtype"
            ],
            "parents": [
                "C3305"
            ]
        },
        {
            "inclusion_indicator": "TREE",
            "is_lead_disease": true,
            "synonyms": [
                "CA",
                "Cancer",
                "Malignancy",
                "Malignant Growth",
                "Malignant Neoplastic Disease",
                "Malignant Tumor",
                "NEOPLASM, MALIGNANT",
                "Neoplasm, malignant",
                "Tumor, malignant, NOS",
                "Unclassified tumor, malignant",
                "cancer",
                "malignancy"
            ],
            "nci_thesaurus_concept_id": "C9305",
            "name": "Malignant Neoplasm",
            "type": [
                "subtype"
            ],
            "parents": [
                "C7062"
            ]
        },
        {
            "inclusion_indicator": "TREE",
            "is_lead_disease": false,
            "synonyms": [
                "CA",
                "Cancer",
                "Malignancy",
                "Malignant Growth",
                "Malignant Neoplastic Disease",
                "Malignant Tumor",
                "NEOPLASM, MALIGNANT",
                "Neoplasm, malignant",
                "Tumor, malignant, NOS",
                "Unclassified tumor, malignant",
                "cancer",
                "malignancy"
            ],
            "nci_thesaurus_concept_id": "C9305",
            "name": "Malignant Neoplasm",
            "type": [
                "subtype"
            ],
            "parents": [
                "C7062"
            ]
        }
    ],
    "_primary_purpose_sort_order": 0,
    "protocol_id": "MC1512",
    "active_sites_count": 1,
    "arms": [
        {
            "interventions": [
                {
                    "inclusion_indicator": "TRIAL",
                    "synonyms": [
                        "Antabuse",
                        "Disulfiram"
                    ],
                    "nci_thesaurus_concept_id": "C447",
                    "name": "Disulfiram",
                    "description": "A carbamoyl derivate used in the treatment of alcoholism. Disulfiram irreversibly inhibits acetaldehyde dehydrogenase that oxidizes the ethanol metabolite acetaldehyde into acetic acid. This leads to an accumulation of acetaldehyde that produces a variety of very unpleasant symptoms referred to as the disulfiram-alcohol reaction. This reaction includes , but is not limited to, flushing, headache, respiratory difficulty, nausea,vomiting, sweating, thirst, chest pain, tachycardia, blurred vision and hypotension. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                    "category": "agent",
                    "type": "Drug",
                    "parents": [
                        "C1742",
                        "C1744",
                        "C2160"
                    ]
                },
                {
                    "inclusion_indicator": "TRIAL",
                    "synonyms": [
                        "Gemzar",
                        "Gemcitabine Hydrochloride"
                    ],
                    "nci_thesaurus_concept_id": "C961",
                    "name": "Gemcitabine Hydrochloride",
                    "description": "The hydrochloride salt of an analogue of the antimetabolite nucleoside deoxycytidine with antineoplastic activity.  Gemcitabine is converted intracellularly to the active metabolites difluorodeoxycytidine di- and triphosphate (dFdCDP, dFdCTP).  dFdCDP inhibits ribonucleotide reductase, thereby decreasing the deoxynucleotide pool available for DNA synthesis; dFdCTP is incorporated into DNA, resulting in DNA strand termination and apoptosis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                    "category": "agent",
                    "type": "Drug",
                    "parents": [
                        "C1557",
                        "C2150"
                    ]
                },
                {
                    "inclusion_indicator": "TRIAL",
                    "synonyms": [
                        "Laboratory Biomarker Analysis"
                    ],
                    "nci_thesaurus_concept_id": "C64263",
                    "name": "Laboratory Biomarker Analysis",
                    "description": null,
                    "category": "other",
                    "type": "Other",
                    "parents": [
                        "C63333",
                        "C74957"
                    ]
                },
                {
                    "inclusion_indicator": "TREE",
                    "synonyms": [
                        "Angiogenesis Antagonists",
                        "Angiogenesis Blockers",
                        "Anti-Angiogenic Agents",
                        "Antiangiogenesis Agents",
                        "Antiangiogenic Agent",
                        "Angiogenesis Inhibitor"
                    ],
                    "nci_thesaurus_concept_id": "C1742",
                    "name": "Angiogenesis Inhibitor",
                    "description": "",
                    "category": "agent category",
                    "type": "Drug",
                    "parents": [
                        "C274"
                    ]
                },
                {
                    "inclusion_indicator": "TREE",
                    "synonyms": [
                        "Anti-Cancer Agents",
                        "Anti-Tumor Agents",
                        "Anti-Tumor Drugs",
                        "Antineoplastic Drugs",
                        "Antineoplastics",
                        "Antiproliferative Agents",
                        "Antiproliferative Drugs",
                        "Cancer Drug",
                        "Chemotherapeutic Agents, Neoplastic Disease",
                        "Tumor-Specific Treatment Agents"
                    ],
                    "nci_thesaurus_concept_id": "C274",
                    "name": "Antineoplastic Agent",
                    "description": "",
                    "category": "agent category",
                    "type": "Drug",
                    "parents": [
                        "C1909"
                    ]
                },
                {
                    "inclusion_indicator": "TREE",
                    "synonyms": [],
                    "nci_thesaurus_concept_id": "C1909",
                    "name": "Pharmacologic Substance",
                    "description": "",
                    "category": "agent category",
                    "type": "Drug",
                    "parents": [
                        "C1908"
                    ]
                },
                {
                    "inclusion_indicator": "TREE",
                    "synonyms": [],
                    "nci_thesaurus_concept_id": "C1908",
                    "name": "Drug, Food, Chemical or Biomedical Material",
                    "description": "",
                    "category": "agent category",
                    "type": "Drug",
                    "parents": []
                },
                {
                    "inclusion_indicator": "TREE",
                    "synonyms": [
                        "Chemopotentiating Agent",
                        "Chemosensitizer",
                        "Chemosensitizing Agent",
                        "MDR Modulators",
                        "Multidrug Resistance Antagonists",
                        "Multidrug Resistance Inhibitors",
                        "Multidrug Resistance Modifier",
                        "Multidrug-Resistance Antagonists",
                        "Multidrug-Resistance Chemo Sensitizers",
                        "Multidrug-Resistance Inhibitors"
                    ],
                    "nci_thesaurus_concept_id": "C1744",
                    "name": "Multidrug Resistance Modulator",
                    "description": "",
                    "category": "agent category",
                    "type": "Drug",
                    "parents": [
                        "C1909"
                    ]
                },
                {
                    "inclusion_indicator": "TREE",
                    "synonyms": [],
                    "nci_thesaurus_concept_id": "C2160",
                    "name": "Proteasome Inhibitor",
                    "description": "",
                    "category": "agent category",
                    "type": "Drug",
                    "parents": [
                        "C471",
                        "C163758"
                    ]
                },
                {
                    "inclusion_indicator": "TREE",
                    "synonyms": [
                        "Enzyme Antagonist",
                        "Enzyme Inhibitor Agent",
                        "Enzyme Inhibitor Drug"
                    ],
                    "nci_thesaurus_concept_id": "C471",
                    "name": "Enzyme Inhibitor",
                    "description": "",
                    "category": "agent category",
                    "type": "Drug",
                    "parents": [
                        "C1909"
                    ]
                },
                {
                    "inclusion_indicator": "TREE",
                    "synonyms": [
                        "Anti-tumor Targeted Therapy Agent",
                        "Molecularly Targeted Therapy Agent",
                        "Targeted Agent",
                        "Targeted Therapeutic Agent"
                    ],
                    "nci_thesaurus_concept_id": "C163758",
                    "name": "Targeted Therapy Agent",
                    "description": "",
                    "category": "agent category",
                    "type": "Drug",
                    "parents": [
                        "C274"
                    ]
                },
                {
                    "inclusion_indicator": "TREE",
                    "synonyms": [],
                    "nci_thesaurus_concept_id": "C1557",
                    "name": "Pyrimidine Antagonist",
                    "description": "",
                    "category": "agent category",
                    "type": "Drug",
                    "parents": [
                        "C272"
                    ]
                },
                {
                    "inclusion_indicator": "TREE",
                    "synonyms": [
                        "Antimetabolites"
                    ],
                    "nci_thesaurus_concept_id": "C272",
                    "name": "Antimetabolite",
                    "description": "",
                    "category": "agent category",
                    "type": "Drug",
                    "parents": [
                        "C274"
                    ]
                },
                {
                    "inclusion_indicator": "TREE",
                    "synonyms": [],
                    "nci_thesaurus_concept_id": "C2150",
                    "name": "Ribonucleotide Reductase Inhibitor",
                    "description": "",
                    "category": "agent category",
                    "type": "Drug",
                    "parents": [
                        "C471"
                    ]
                },
                {
                    "inclusion_indicator": "TREE",
                    "synonyms": [
                        "Biomarker Analysis"
                    ],
                    "nci_thesaurus_concept_id": "C63333",
                    "name": "Biomarker Analysis",
                    "description": "",
                    "category": "none",
                    "type": "Other",
                    "parents": [
                        "C25218"
                    ]
                },
                {
                    "inclusion_indicator": "TREE",
                    "synonyms": [],
                    "nci_thesaurus_concept_id": "C25218",
                    "name": "Intervention or Procedure",
                    "description": "",
                    "category": "none",
                    "type": "Other",
                    "parents": [
                        "C16203"
                    ]
                },
                {
                    "inclusion_indicator": "TREE",
                    "synonyms": [],
                    "nci_thesaurus_concept_id": "C16203",
                    "name": "Clinical or Research Activity",
                    "description": "",
                    "category": "none",
                    "type": "Other",
                    "parents": [
                        "C43431"
                    ]
                },
                {
                    "inclusion_indicator": "TREE",
                    "synonyms": [],
                    "nci_thesaurus_concept_id": "C43431",
                    "name": "Activity",
                    "description": "",
                    "category": "none",
                    "type": "Other",
                    "parents": []
                },
                {
                    "inclusion_indicator": "TREE",
                    "synonyms": [],
                    "nci_thesaurus_concept_id": "C74957",
                    "name": "Mixed Category Laboratory Procedure",
                    "description": "",
                    "category": "none",
                    "type": "Other",
                    "parents": [
                        "C25294"
                    ]
                },
                {
                    "inclusion_indicator": "TREE",
                    "synonyms": [
                        "Lab Test",
                        "Lab Tests",
                        "Laboratory Test",
                        "Test",
                        "Tests",
                        "Laboratory Procedure"
                    ],
                    "nci_thesaurus_concept_id": "C25294",
                    "name": "Laboratory Procedure",
                    "description": "",
                    "category": "none",
                    "type": "Other",
                    "parents": [
                        "C25218"
                    ]
                }
            ],
            "name": "Cohort I (gemcitabine hydrochloride and disulfiram)",
            "description": "Patients receive gemcitabine hydrochloride IV over 30 minutes on days 1, 8, and 15 and disulfiram PO on days 1-28 or days 1-35.",
            "type": "EXPERIMENTAL"
        },
        {
            "interventions": [
                {
                    "intervention_type": "Drug",
                    "inclusion_indicator": "TRIAL",
                    "synonyms": [
                        "Antabuse",
                        "Disulfiram"
                    ],
                    "intervention_name": "Disulfiram",
                    "category": "agent",
                    "intervention_code": "C447",
                    "intervention_description": "A carbamoyl derivate used in the treatment of alcoholism. Disulfiram irreversibly inhibits acetaldehyde dehydrogenase that oxidizes the ethanol metabolite acetaldehyde into acetic acid. This leads to an accumulation of acetaldehyde that produces a variety of very unpleasant symptoms referred to as the disulfiram-alcohol reaction. This reaction includes , but is not limited to, flushing, headache, respiratory difficulty, nausea,vomiting, sweating, thirst, chest pain, tachycardia, blurred vision and hypotension. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                    "parents": [
                        "C1742",
                        "C1744",
                        "C2160"
                    ]
                },
                {
                    "intervention_type": "Other",
                    "inclusion_indicator": "TRIAL",
                    "synonyms": [
                        "Laboratory Biomarker Analysis"
                    ],
                    "intervention_name": "Laboratory Biomarker Analysis",
                    "category": "other",
                    "intervention_code": "C64263",
                    "intervention_description": null,
                    "parents": [
                        "C63333",
                        "C74957"
                    ]
                },
                {
                    "inclusion_indicator": "TRIAL",
                    "synonyms": [
                        "Chemotherapy"
                    ],
                    "nci_thesaurus_concept_id": "C15632",
                    "name": "Chemotherapy",
                    "description": null,
                    "category": "agent",
                    "type": "Drug",
                    "parents": [
                        "C49236"
                    ]
                },
                {
                    "intervention_type": "Drug",
                    "inclusion_indicator": "TREE",
                    "synonyms": [
                        "Angiogenesis Antagonists",
                        "Angiogenesis Blockers",
                        "Anti-Angiogenic Agents",
                        "Antiangiogenesis Agents",
                        "Antiangiogenic Agent",
                        "Angiogenesis Inhibitor"
                    ],
                    "intervention_name": "Angiogenesis Inhibitor",
                    "category": "agent category",
                    "intervention_code": "C1742",
                    "intervention_description": "",
                    "parents": [
                        "C274"
                    ]
                },
                {
                    "intervention_type": "Drug",
                    "inclusion_indicator": "TREE",
                    "synonyms": [
                        "Anti-Cancer Agents",
                        "Anti-Tumor Agents",
                        "Anti-Tumor Drugs",
                        "Antineoplastic Drugs",
                        "Antineoplastics",
                        "Antiproliferative Agents",
                        "Antiproliferative Drugs",
                        "Cancer Drug",
                        "Chemotherapeutic Agents, Neoplastic Disease",
                        "Tumor-Specific Treatment Agents"
                    ],
                    "intervention_name": "Antineoplastic Agent",
                    "category": "agent category",
                    "intervention_code": "C274",
                    "intervention_description": "",
                    "parents": [
                        "C1909"
                    ]
                },
                {
                    "intervention_type": "Drug",
                    "inclusion_indicator": "TREE",
                    "synonyms": [],
                    "intervention_name": "Pharmacologic Substance",
                    "category": "agent category",
                    "intervention_code": "C1909",
                    "intervention_description": "",
                    "parents": [
                        "C1908"
                    ]
                },
                {
                    "intervention_type": "Drug",
                    "inclusion_indicator": "TREE",
                    "synonyms": [],
                    "intervention_name": "Drug, Food, Chemical or Biomedical Material",
                    "category": "agent category",
                    "intervention_code": "C1908",
                    "intervention_description": "",
                    "parents": []
                },
                {
                    "intervention_type": "Drug",
                    "inclusion_indicator": "TREE",
                    "synonyms": [
                        "Chemopotentiating Agent",
                        "Chemosensitizer",
                        "Chemosensitizing Agent",
                        "MDR Modulators",
                        "Multidrug Resistance Antagonists",
                        "Multidrug Resistance Inhibitors",
                        "Multidrug Resistance Modifier",
                        "Multidrug-Resistance Antagonists",
                        "Multidrug-Resistance Chemo Sensitizers",
                        "Multidrug-Resistance Inhibitors"
                    ],
                    "intervention_name": "Multidrug Resistance Modulator",
                    "category": "agent category",
                    "intervention_code": "C1744",
                    "intervention_description": "",
                    "parents": [
                        "C1909"
                    ]
                },
                {
                    "intervention_type": "Drug",
                    "inclusion_indicator": "TREE",
                    "synonyms": [],
                    "intervention_name": "Proteasome Inhibitor",
                    "category": "agent category",
                    "intervention_code": "C2160",
                    "intervention_description": "",
                    "parents": [
                        "C471",
                        "C163758"
                    ]
                },
                {
                    "intervention_type": "Drug",
                    "inclusion_indicator": "TREE",
                    "synonyms": [
                        "Enzyme Antagonist",
                        "Enzyme Inhibitor Agent",
                        "Enzyme Inhibitor Drug"
                    ],
                    "intervention_name": "Enzyme Inhibitor",
                    "category": "agent category",
                    "intervention_code": "C471",
                    "intervention_description": "",
                    "parents": [
                        "C1909"
                    ]
                },
                {
                    "intervention_type": "Drug",
                    "inclusion_indicator": "TREE",
                    "synonyms": [
                        "Anti-tumor Targeted Therapy Agent",
                        "Molecularly Targeted Therapy Agent",
                        "Targeted Agent",
                        "Targeted Therapeutic Agent"
                    ],
                    "intervention_name": "Targeted Therapy Agent",
                    "category": "agent category",
                    "intervention_code": "C163758",
                    "intervention_description": "",
                    "parents": [
                        "C274"
                    ]
                },
                {
                    "intervention_type": "Other",
                    "inclusion_indicator": "TREE",
                    "synonyms": [
                        "Biomarker Analysis"
                    ],
                    "intervention_name": "Biomarker Analysis",
                    "category": "none",
                    "intervention_code": "C63333",
                    "intervention_description": "",
                    "parents": [
                        "C25218"
                    ]
                },
                {
                    "intervention_type": "Other",
                    "inclusion_indicator": "TREE",
                    "synonyms": [],
                    "intervention_name": "Intervention or Procedure",
                    "category": "none",
                    "intervention_code": "C25218",
                    "intervention_description": "",
                    "parents": [
                        "C16203"
                    ]
                },
                {
                    "intervention_type": "Other",
                    "inclusion_indicator": "TREE",
                    "synonyms": [],
                    "intervention_name": "Clinical or Research Activity",
                    "category": "none",
                    "intervention_code": "C16203",
                    "intervention_description": "",
                    "parents": [
                        "C43431"
                    ]
                },
                {
                    "intervention_type": "Other",
                    "inclusion_indicator": "TREE",
                    "synonyms": [],
                    "intervention_name": "Activity",
                    "category": "none",
                    "intervention_code": "C43431",
                    "intervention_description": "",
                    "parents": []
                },
                {
                    "intervention_type": "Other",
                    "inclusion_indicator": "TREE",
                    "synonyms": [],
                    "intervention_name": "Mixed Category Laboratory Procedure",
                    "category": "none",
                    "intervention_code": "C74957",
                    "intervention_description": "",
                    "parents": [
                        "C25294"
                    ]
                },
                {
                    "intervention_type": "Other",
                    "inclusion_indicator": "TREE",
                    "synonyms": [
                        "Lab Test",
                        "Lab Tests",
                        "Laboratory Test",
                        "Test",
                        "Tests",
                        "Laboratory Procedure"
                    ],
                    "intervention_name": "Laboratory Procedure",
                    "category": "none",
                    "intervention_code": "C25294",
                    "intervention_description": "",
                    "parents": [
                        "C25218"
                    ]
                },
                {
                    "inclusion_indicator": "TREE",
                    "synonyms": [],
                    "nci_thesaurus_concept_id": "C49236",
                    "name": "Therapeutic Procedure",
                    "description": "",
                    "category": "agent category",
                    "type": "Drug",
                    "parents": [
                        "C25218"
                    ]
                }
            ],
            "name": "Cohort II (chemotherapy and disulfiram)",
            "description": "Patients receive chemotherapy at the discretion of the treating oncologist and disulfiram PO on days 1-28 or days 1-35.",
            "type": "EXPERIMENTAL"
        }
    ],
    "study_model_code": null,
    "nci_id": "NCI-2016-00007",
    "why_study_stopped": "expiration of study drug supply, will re-open after re-supply which we anticipate will be shortly",
    "brief_summary": "This partially randomized phase I trial studies the side effects and best dose of disulfiram when given together with chemotherapy in treating patients with a solid tumor that does not respond to treatment (refractory) or pancreatic cancer that has spread to other places in the body (metastatic) and to compare whether disulfiram and chemotherapy may reduce tumor induced muscle loss. Weight loss occurs in pancreatic cancer patients and is common in a multitude of other cancers. Patients with metastatic cancer and weight loss sometimes are not able to receive treatment due to physical weakness or debility. Disulfiram is a potential inhibitor of muscle degradation and may reduce tumor induced muscle wasting. Disulfiram may also help chemotherapy work better by making tumor cells more sensitive to the drug. Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not yet known whether giving chemotherapy with or without disulfiram is a better treatment for refractory solid tumors or metastatic pancreatic cancer.",
    "brief_title": "Disulfiram and Chemotherapy in Treating Patients with Refractory Solid Tumors or Metastatic Pancreatic Cancer",
    "study_population_description": null,
    "sampling_method_code": null,
    "minimum_target_accrual_number": 74,
    "_current_trial_status_sort_order": 4,
    "start_date": "2016-02-25",
    "record_verification_date": "2022-01-10",
    "ctep_id": null,
    "current_trial_status": "Temporarily Closed to Accrual",
    "study_model_other_text": null,
    "masking": {
        "role_caregiver": null,
        "masking": "DOUBLE_BLIND",
        "role_investigator": null,
        "role_outcome_assessor": null,
        "role_subject": null,
        "allocation_code": "Non-Randomized Trial"
    },
    "acronym": null,
    "anatomic_sites": [
        "Multiple"
    ],
    "ccr_id": null,
    "start_date_type_code": "ACTUAL",
    "principal_investigator": "Aminah Jatoi",
    "study_source": "Institutional",
    "completion_date": "2022-05-05",
    "study_subtype_code": null,
    "study_protocol_type": "Interventional"
}